A Subcutaneous Shift in Diabetic Ketoacidosis Management

Add to Calendar A Subcutaneous Shift in Diabetic Ketoacidosis Management 11/4/2024 12:00:00 PM 11/4/2024 1:00:00 PM America/New_York For More Details: https://rutgers.cloud-cme.com/course/courseoverview?EID=25592 Description: The purpose of this activity is to review the 2024 American Diabetes Association Hyperglycemic Crisis guidelines with a discussion of subcutaneous insulin as a treatment for diabetic ketoacidosis. The activity will describe the potential impact of the 2024 Hyperglycemic crisis guideline on patient management as well as review primary literature supporting guideline recommendations. With significant c... false MM/DD/YYYY


Date & Location
Monday, November 4, 2024, 12:00 PM - 1:00 PM

Overview
The purpose of this activity is to review the 2024 American Diabetes Association Hyperglycemic Crisis guidelines with a discussion of subcutaneous insulin as a treatment for diabetic ketoacidosis.  The activity will describe the potential impact of the 2024 Hyperglycemic crisis guideline on patient management as well as review primary literature supporting guideline recommendations.  With significant change and emphasis on utilization of subcutaneous insulin for diabetic ketoacidosis in the 2024 guidelines, focus will be placed on patient evaluation / selection for subcutaneous insulin therapy and considerations for practice.  Currently, subcutaneous insulin is underutilized for diabetic ketoacidosis in practice.  Patients are not routinely stratified by severity of diabetic ketoacidosis, and as such are often treated with IV insulin, resulting in an increased amount of ICU admissions for mild diabetic ketoacidosis.  The goal of this activity is to provide education and literature to support a practice change towards patient-specific care for diabetic ketoacidosis.  

Target Audience
Specialties - General Pharmacy
Professions - Pharmacist

Objectives
  Upon completion of this activity, participants should be better able to:

 


  1. Recognize key changes to diabetic Ketoacidosis management outlined in the 2024 American Diabetes Association (ADA) Hyperglycemic Crises Consensus Report.
  2. Identify opportunities for improvement in the management of diabetic ketoacidosis.
  3. Describe the elements of a patient-centered treatment regimen based on diabetic ketoacidosis severity.

Registration

REGISTRATION CLOSES PROMPTLY ON NOV 3RD AT 11AM.  You must complete the evaluation AFTER this CE activity by Nov. 18th to be considered for credit.


Accreditation and Credit Designation

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credits
ACPE Credits (1.00 hours)